RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia

Published:2022-07 Issue:7 Volume:24 Page:803-822
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Shanmuganathan Naranie^ORCID,Wadham Carol^ORCID,Thomson Daniel,Shahrin Nur Hezrin^ORCID,Vignaud Chloe,Obourn Vanessa,Chaturvedi Shalini,Yang Feng,Feng Jinghua,Saunders Verity^ORCID,Kok Chung H.,Yeung David,King Rob M.,Kenyon Rosalie R.,Lin Ming,Wang Paul^ORCID,Scott Hamish^ORCID,Hughes Timothy,Schreiber Andreas W.^ORCID,Branford Susan

Funder

Bristol-Myers Squibb

Tasmanian Department of Health

Cancer Council Tasmania

Novartis

Department of Health, Australian Government

Gilead Sciences

Royal Adelaide Hospital

Janssen Pharmaceuticals

Ray and Shirl Norman Cancer Research Trust

Amgen

Royal Adelaide Hospital Research Fund

National Health and Medical Research Council

Government of South Australia

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference61 articles.

1. HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions;Bruford;Leukemia,2021

2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

3. ABL1 fusion genes in hematological malignancies: a review;De Braekeleer;Eur J Haematol,2011

4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

5. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial;Hochhaus;Leukemia,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond BCR::ABL1—The Role of Genomic Analyses in the Management of CML;Journal of the National Comprehensive Cancer Network;2024-02

2. Accelerated-phase CML: de novo and transformed;Hematology;2023-12-08

3. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia;Leukemia;2023-10-04

4. Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention;Haematologica;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3